Pembrolizumab plus pomalidomide and dexamethasone for...

  • Main
  • 2019 / 7
  • Pembrolizumab plus pomalidomide and dexamethasone for...

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

Mateos, Maria-Victoria, Blacklock, Hilary, Schjesvold, Fredrik, Oriol, Albert, Simpson, David, George, Anupkumar, Goldschmidt, Hartmut, Larocca, Alessandra, Chanan-Khan, Asher, Sherbenou, Daniel, Aviv
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30110-3
Date:
July, 2019
File:
PDF, 355 KB
2019
Conversion to is in progress
Conversion to is failed